| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/04/2009 | WO2009068668A1 New therapeutic approaches for treating cmt and related disorders |
| 06/04/2009 | WO2009068190A2 Combinations comprising a prostaglandin and uses thereof |
| 06/04/2009 | WO2009067820A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | WO2009067791A1 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 06/04/2009 | WO2009067790A1 STIMULATION OF HYPOXIA INDUCIBLE FACTOR -1 ALPHA (HIF-1α) FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE (CDAD), FOR INTESTINAL MOTILITY AND FOR DETECTING INFECTION |
| 06/04/2009 | WO2009022179A3 Glucokinase activators in the treatment of osteoarthritis |
| 06/04/2009 | WO2008143880A3 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 06/04/2009 | WO2008125828A3 Oligo-guluronate and galacturonate compositions |
| 06/04/2009 | WO2006110831A3 Method of inducing neutralizing antibodies to human immunodeficiency virus |
| 06/04/2009 | US20090143724 Microprojection Array Immunization Patch and Method |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143477 Antimicrobial Nanoemulsion Compositions and Methods |
| 06/04/2009 | US20090143476 Antimicrobial Nanoemulsion Compositions and Methods |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143314 Compositions and methods for combination antiviral therapy |
| 06/04/2009 | US20090143308 Yeast membrane protein expression system and its application in drug screening |
| 06/04/2009 | US20090142453 Nutraceutical Coatings fo Fruits and Vegetables |
| 06/04/2009 | US20090142427 Composition and its Therapeutic Use |
| 06/04/2009 | US20090142392 Composition Comprising a NSAID and Paracetamol |
| 06/04/2009 | US20090142358 Human antibodies specific to kdr and uses thereof |
| 06/04/2009 | US20090142351 Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof |
| 06/04/2009 | US20090142334 DETECTION AND MODULATION OF IAPs AND NAIP FOR THE DIAGNOSIS AND TREATMENT OF PROLIFERATIVE DISEASE |
| 06/04/2009 | US20090142315 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption |
| 06/04/2009 | US20090142310 Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides |
| 06/04/2009 | US20090142308 Methods for treating autoimmune disease by inducing autoantigen-specific regulatory CD4+ T cells |
| 06/04/2009 | US20090142296 Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue |
| 06/04/2009 | US20090142278 Effervescent Compositions Comprising Phosphonates and Methods Related Thereto |
| 06/04/2009 | DE102008053348A1 Medicament useful for suppressing the immune system, treating necrotic cell death, ischemia, hypoxia, trauma, diabetes mellitus, myocardial infarction and/or cerebral ischemia, and treating the patients after resustication |
| 06/04/2009 | CA2706742A1 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 06/04/2009 | CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | CA2706479A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | CA2706445A1 Method of increasing immunological effect |
| 06/04/2009 | CA2705408A1 New therapeutic approaches for treating cmt and related disorders |
| 06/04/2009 | CA2694572A1 Drug for alleviating motor complications or psychiatric symptoms of parkinson's disease |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065054A1 Combinations comprising a prostaglandin and uses thereof |
| 06/03/2009 | EP2065053A1 Cell death inhibitor |
| 06/03/2009 | EP2065050A1 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 06/03/2009 | EP2065044A1 Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
| 06/03/2009 | EP2065041A1 Use of medium chain triglycerides for the treatment and prevention of Parkinson's disease, Huntington' disease or Amyloid Lateral Sclerosis resulting from reduced neuronal metabolism |
| 06/03/2009 | EP2064951A1 Use of a substituted imidazole, derivatives or salts thereof for the preparation of a medicament for the treatment of a cell proliferative disorder |
| 06/03/2009 | EP2063886A2 Use of n-containing spirocompounds for the enhancement of cognitive function |
| 06/03/2009 | EP2063879A2 Compositions of chk1 inhibitors and cyclodextrin |
| 06/03/2009 | EP2063875A2 Combination pharmaceutical compositions |
| 06/03/2009 | EP2063873A2 Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
| 06/03/2009 | EP2063865A1 Long term 24 hour intestinal administration of levodopa/carbidopa |
| 06/03/2009 | EP1633339A4 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 06/03/2009 | EP1575533B1 Topical compositions having a natural ingredient and method of use |
| 06/03/2009 | EP1480618B1 Sustained release drug formulations containing a carrier peptide |
| 06/03/2009 | EP1366759B1 Tablets quickly disintegrating in oral cavity |
| 06/03/2009 | EP1307454B1 Derivatives of variolin b |
| 06/03/2009 | EP1253853B1 Method for classifying physiologic brain imbalances using quantitative eeg |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | EP1140079B1 Assays for ligands for nuclear receptors |
| 06/03/2009 | EP0985032B2 Ribosome complexes as selection particles for in vitro display and evolution of proteins |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN101445463A Beta2-adrenergic receptor agonists |
| 06/03/2009 | CN101444626A Stable medical composite containing biguanide, sulfonylurea and thiazolidinedione and preparation method thereof |
| 06/03/2009 | CN101444625A Treatment medicine capable of degrading high-polymer tumor and sustained-release medicine for normal cell protective agent |
| 06/03/2009 | CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 06/03/2009 | CN101444470A Use of oligosaccharides to stimulate beta-endorphin production |
| 06/03/2009 | CN100493647C Sustained release of an active agent using an implantable system |
| 06/03/2009 | CN100493614C Anticancer medicine-chitosan complex for forming self-aggregates and preparation method thereof |
| 06/03/2009 | CN100493609C Medicine composition for treating malignant tumours and application |
| 06/03/2009 | CN100493608C Production of aerosol containing biological activity |
| 06/03/2009 | CN100493603C Gonadoliberin double-way genital regulating medicine and reproduction of fish |
| 06/03/2009 | CN100493602C Gonadoliberin double-way genital regulating medicine and reproduction of fowl |
| 06/02/2009 | US7541443 A humanized antibody for use as immunosuppressants, treating or preventing transplant rejection in human patient; drug screening |
| 06/02/2009 | US7541435 Antagonists of cxcr3-binding cxc chemokines |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | US7541362 7-(3,4-Dichlorophenyl)-4,7-dihydro-5-methyl-6-(5-phenyl-2-oxazolyl)pyrazolo[1, 5-a]pyrimidine |
| 06/02/2009 | US7541337 Methods and compositions for the treatment of peripheral artery disease |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541329 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/02/2009 | US7541153 Screening a substance interfering in the association of Dedicator of cytokinesis 2 (DOCK2) and engulfment and cell motility 1(ELMO1); drug screening; allergy, autoimmune diseases, GvH, graft rejection |
| 06/02/2009 | US7541047 Method for production of shaped body for treating wounds in milk producing animals |
| 06/02/2009 | US7541042 Topical compositions containing Bacillus coagulans extracellular products and uses thereof |
| 06/02/2009 | US7541041 Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans |
| 06/02/2009 | US7541039 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/02/2009 | US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors |
| 06/02/2009 | US7541027 polyclonal antibodies, monoclonal antibodies, F(ab')2, Fab and single chain Fv; tyrosine at position 1214 in the amino acid sequence of the vascular endothelial growth factor receptor |
| 06/02/2009 | CA2512475C Compositions and methods for combination antiviral therapy |
| 06/02/2009 | CA2450868C Non-nucleoside reverse transcriptase inhibitors |
| 06/02/2009 | CA2450787C Active ingredient combination for pharmacological addictive substance or intoxicant therapy |
| 06/02/2009 | CA2425395C Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 06/02/2009 | CA2410160C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 06/02/2009 | CA2395364C Model animal with onset of collagen-induced arthritis |
| 06/02/2009 | CA2371728C High dose radionuclide complexes for bone marrow suppression |
| 06/02/2009 | CA2350425C Use of an insulin sensitiser for the treatment of type 2 diabetes mellitus |
| 06/02/2009 | CA2349633C A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 06/02/2009 | CA2321664C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/02/2009 | CA2244089C Dermal penetration enhancers and drug delivery systems involving same |
| 06/02/2009 | CA2211802C Pharmaceutical composition for the treatment of herpes |
| 06/02/2009 | CA2158475C Composition and method for reducing toxicity of biologically-active factors |
| 05/28/2009 | WO2009067296A1 Treatment of oral pharyngeal dysphagia |
| 05/28/2009 | WO2009065947A2 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids |
| 05/28/2009 | WO2009065395A2 Novel use of omega-3-fatty acid(s) |